Skip to main content
. 2000 Apr 24;2000(2):CD002139. doi: 10.1002/14651858.CD002139

a07 OLCSG 1b.

Methods RCT ‐ 1982‐86
Participants 83 patients
Interventions surgery vs surgery + chemotherapy
 doxorubicin 100§
 mitomycin C 20§
 tegafur(a)* 600‐800§
 tegafur(b)* 600‐800§
Outcomes survival
Notes doxorubicin given in 3 cycles
 tegafur (a) daily treatment
 tegafur (b) daily treatment > 1 year
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Low risk A ‐ Adequate